FDAnews
www.fdanews.com/articles/123528-boston-scientific-stent-inferior-to-abbott-labs-8217-study-says

Boston Scientific Stent Inferior to Abbott Labs’, Study Says

January 8, 2010
Boston Scientific Corp.’s Taxus Liberte stent shouldn’t be used in routine clinical practice because it’s inferior in terms of safety and efficacy to Abbott Laboratories’ Xience V product, said researchers writing in The Lancet medical journal.
Daily Herald